Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 1.00 |
| ▸ | SLC28A2 | O43868 | 1/20 | 1.00 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 1.00 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 1.00 |
| ▸ | P2RY2 | P41231 | 11/20 | 0.69 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.65 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.63 |
| ▸ | P2RY14 | Q15391 | 7/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine SCHEMBL14853938 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2056533 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL329746 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL10815678 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2056827 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL9060684 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL375985 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Arauridine SCHEMBL359587 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL7752140 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL20987631 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114672455-B | Method for inducing bone marrow stromal cells by utilizing pluripotent stem cells | 中山大学 | 2024-07-09 | — | — | CN | claimed |
| US-20130183765-A1 | Ultraviolet and High-Performance Liquid Chromatography Methods for the Evaluation of Sunscreen Efficacy | Sena Research Incorporated (US) | 2013-07-18 | — | — | US | claimed |
| CN-114672455-B | Method for inducing bone marrow stromal cells by utilizing pluripotent stem cells | 中山大学 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024005737-A1 | NANOFIBER WOUND DRESSING WITH URIDINE | BURSA ULUDAĞ ÜNİVERSİTESİ (TR) | 2024-01-04 | — | — | WO | disclosed |
| CN-116615246-A | Multi-conjugates comprising monosubstituted homo-divalent linkers | MPEG LA有限责任公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-115997019-A | Polyoligonucleotide with strand separation | MPEG LA有限责任公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-3675838-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | Puretecch LYT, Inc. (US) | 2020-07-08 | — | — | EP | disclosed |
| WO-2019046491-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | ARIYA THERAPEUTICS, INC. (US) | 2019-03-07 | — | — | WO | disclosed |
| US-10073033-B2 | Ultraviolet and high-performance liquid chromatography methods for the evaluation of sunscreen efficacy | SENA RESEARCH, INC. (US) | 2018-09-11 | — | — | US | disclosed |
| CN-108079982-A | A kind of modified silica-gel filler, preparation method and purposes | 苏州纳微科技有限公司 | 2018-05-29 | — | — | CN | disclosed |
| CN-102203253-B | Multi-exon skipping compositions for DMD | SAREPTA THERAPEUTICS, INC. (US) | 2016-04-06 | — | — | CN | disclosed |
| CN-104515817-A | Method for evaluating destroy degree on nucleotide of determination method and production technology of free nucleic acid hydrolysate in protein product | SHANGHAI GENTECH FEED CO LTD | 2015-04-15 | — | — | CN | disclosed |
| US-20130183765-A1 | Ultraviolet and High-Performance Liquid Chromatography Methods for the Evaluation of Sunscreen Efficacy | Sena Research Incorporated (US) | 2013-07-18 | — | — | US | disclosed |
| CN-102203253-A | Multi-exon skipping compositions for DMD | AVI BIOPHARMA INC | 2011-09-28 | — | — | CN | disclosed |
| WO-2011060271-A1 | SCREENING FOR INHIBITORS OF P. FALCIPARUM USING LUCIFERASE BASED HIGH THROUGHPUT SCREENING ASSAY | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2008109120-A2 | P53-MEDIATED SKIN PIGMENTATION | DANA-FARBER CANCER INSTITUTE (US) | 2008-09-12 | — | — | WO | disclosed |
| CN-101200755-A | Bacterium identification reagent kit as well as preparation method and uses thereof | UNIV SOUTH CHINA AGRICULT (CN) | 2008-06-18 | — | — | CN | disclosed |
| WO-2008066707-A2 | TARGETING PROHORMONE CONVERTASE ENZYMES TO SUPPRESS POMC-MSH PROCESSING TO INDUCE SKIN LIGHTENING | DANA-FARBER CANCER INSTITUTE (US) | 2008-06-05 | — | — | WO | disclosed |